Drug Discovery ¼­ºñ½º¿ë ¾çÀÚ ÄÄÇ»ÆÃ ½ÃÀå : Drug Discovery ¼­ºñ½ºº°, Ä¡·á ºÐ¾ßº°, ÁÖ¿ä Áö¿ªº° : ¾÷°è µ¿Çâ°ú ¼¼°è ¿¹Ãø(2023-2035³â)
Quantum Computing in Drug Discovery Services Market: Distribution by Drug Discovery Service Offered, Therapeutic Area, and Key Geographical Regions : Industry Trends and Global Forecasts, 2023-2035
»óǰÄÚµå : 1226687
¸®¼­Ä¡»ç : Roots Analysis
¹ßÇàÀÏ : 2023³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 178 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,799 £Ü 6,606,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,999 £Ü 9,635,000
PDF (One-Location Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ Æ¯Á¤ »ç¾÷ ºÎ¹®¿¡ ¼ÓÇÑ ¸ðµç ºÐµéÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,599 £Ü 14,591,000
PDF (Department License) help
PDF º¸°í¼­¸¦ ºÎ¼­ ´ÜÀ§·Î 12¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,999 £Ü 24,779,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Drug Discovery ¼­ºñ½º¿ë ¾çÀÚ ÄÄÇ»ÆÃ ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, Á¦°øÇÏ´Â Drug Discovery ¼­ºñ½ºº°, Ä¡·á ºÐ¾ßº°, ÁÖ¿ä Áö¿ªº° µ¿Çâ, Áö¿ªº° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼­·Ð

Á¦4Àå ½ÃÀå ±¸µµ : ¼ÒÇÁÆ®¿þ¾î Á¦°ø¾÷ü

Á¦5Àå ±â¾÷ °æÀï·Â ºÐ¼®

Á¦6Àå ±â¾÷ °³¿ä : ¼ÒÇÁÆ®¿þ¾î Á¦°ø¾÷ü

Á¦7Àå ½ÃÀå ±¸µµ : Çϵå¿þ¾î Á¦°ø¾÷ü

Á¦8Àå ±â¾÷ °³¿ä : Çϵå¿þ¾î Á¦°ø¾÷ü

Á¦9Àå Çмú º¸Á¶±Ý ºÐ¼®

Á¦10Àå ÆÄÆ®³Ê½Ê ¹× Çù¾÷

Á¦11Àå »ç¿ë »ç·Ê ½ºÅ͵ð

Á¦12Àå Porter's Five Forces ºÐ¼®

Á¦13Àå ºí·ç¿À¼Ç Àü·« : ½Å±Ô ±â¾÷ÀÌ °æÀïÀÌ Ä¡¿­ÇÑ ½ÃÀå¿¡ Âü¿©Çϱâ À§ÇÑ Àü·« °¡À̵å

Á¦14Àå ½ÃÀå ±Ô¸ð¿Í ±âȸ ºÐ¼®

Á¦15Àå ÁÖ¿ä ÀλçÀÌÆ®

Á¦16Àå ºÎ·Ï 1 : Ç¥ Çü½Ä µ¥ÀÌÅÍ

Á¦17Àå ºÎ·Ï 2 : ±â¾÷ ¹× Á¶Á÷ ¸®½ºÆ®

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

INTRODUCTION

The early stages of research related to drug discovery, including the identification of a relevant biological target and a viable lead compound, play an important role in the overall success of a drug candidate in preclinical and clinical studies. The process of drug development, beginning from the discovery of a pharmacological lead to its commercial launch, is estimated to take around 10-15 years, involving capital investments in the range of USD 4 billion - USD 10 billion. Over time, the complexities associated with drug discovery have increased, specifically, for large molecules, which are inherently more complex than small molecule drugs. In order to overcome various challenges related to drug discovery, such as rising capital requirements and failure of late-stage programs, several pharmaceutical players are currently exploring the implementation of quantum computing in drug discovery processes. Quantum computing is a process that uses laws of quantum mechanics to solve large and complex problems in a short span as compared to the computer aided drug discovery. Currently, there are several quantum computing related approaches that are being used in the drug discovery process alone, such as structure-based drug design, fragment-based drug discovery and ligand-based drug discovery. The predictive power of quantum computing has proven to reduce the complexity, cost and time investment in the overall drug discovery procedure by allowing researchers to bypass the random screening of billions of molecules in a short span of time. As a result, the pharmaceutical industry stakeholders have started relying on the players offering services for quantum computing in drug discovery. Furthermore, considering the various initiatives being undertaken actively by players based in this domain, we are led to believe that the opportunity for stakeholders in this niche, upcoming industry is likely to grow at a steady pace in the foreseen future.

SCOPE OF THE REPORT

"The Quantum Computing in Drug Discovery Services Market: Distribution by Drug Discovery Service Offered (Target Identification / Validation, Hit Generation / Lead Identification and Lead Optimization), Therapeutic Area (Cardiovascular Disorders, CNS Disorders, Dermatological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Immunological Disorders, Infectious Diseases, Musculoskeletal Disorders, Oncological Disorders, Respiratory Disorders and Others), and Key Geographical Regions (North America (US and Canada), Europe (UK, France, Germany and Rest of the Europe), Asia-Pacific (China, Japan and Rest of the Asia Pacific), Latin America and Middle East and North Africa): Industry Trends and Global Forecasts, 2023-2035" report features an extensive study of the current market landscape and future potential of quantum computing in drug discovery services market. The report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the pharmaceutical industry. The report answers many key questions related to this domain.

What is quantum computing and how does it work in drug discovery?

Quantum computing is a rapidly emerging technology that uses quantum mechanism to solve large and complex problems in a short span of time as compared to traditional computers. Presently, quantum computing is used for the discovery and development of drugs owing to its capability of screening billions of molecules for specific targets in a short span of time. This procedure reduces the complexity and helps in saving time and cost associated with the drug discovery process.

What is the current market landscape of the quantum computing market focused on drug discovery?

The current market landscape of quantum computing comprises of both software and hardware providers. Software providers claim to offer services across various types of drug discovery steps. Further, these are focused on different types of therapeutic areas, primarily including oncological disorders, infectious diseases and cardiovascular disorders. Hardware providers primarily offer hardware as a service; some of the players also offer the option of purchasing the hardware directly.

What are the key trends across grants awarded for quantum computing in drug discovery?

Currently, more than 170 grants have been awarded to various organizations, primarily focused on quantum computing in drug discovery. Further, it is important to mention that the maximum number of grants have been awarded under type 5 category.

What are the key trends in the partnerships and collaborations for quantum computing in drug discovery?

Currently, various partnerships have been inked for quantum computing in drug discovery domain. Majority of these partnerships are research and development agreements, followed by platform utilization agreements.

What is the impact of quantum computing on the pharmaceutical industry?

Quantum computing has created a huge impact on the pharmaceutical industry in a short time period. Various industry stakeholders are integrating quantum computing for the discovery and development of drugs. Owing to the various benefits of quantum computing, such as big data processing and complex molecular modeling for minimizing cost and time investment, the adoption rate in pharmaceutical industry is expected to increase rapidly in the coming future.

What is the market size of quantum computing in drug discovery services market?

As the adoption of quantum computing in drug discovery increases amongst innovators in the pharmaceutical and biopharmaceutical industries, lucrative opportunities are expected to emerge for players offering services for quantum computing in drug discovery. The global quantum computing market, focused on drug discovery is expected to grow at a CAGR of 14% from 2023 to 2035.

Who are the players in the quantum computing in drug discovery services market?

Examples of service providers engaged in this domain (which have also been captured in this report) include (in alphabetic order) Accenture, Aurora Fine Chemicals, Amazon Web Services, Huawei, IBM, Microsoft, Fujitsu, Xanadu and XtalPi.

The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes:

One of the key objectives of the report was to estimate the current opportunity and future growth potential of quantum computing in drug discovery services market over the coming years. We have provided informed estimates on the likely evolution of the market for the period, 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as drug discovery services offered (target identification / validation, hit generation / lead identification and lead optimization), therapeutic area (cardiovascular disorders, CNS disorders, dermatological disorders, endocrine disorders, gastrointestinal disorders, immunological disorders, infectious diseases, musculoskeletal disorders, oncological disorders, respiratory disorders and others), and key geographical regions ((North America (US and Canada), Europe (UK, France, Germany and Rest of the Europe), Asia-Pacific (China, Japan and Rest of the Asia Pacific), Latin America and Middle East and North Africa). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry's evolution.

The opinions and insights presented in the report were influenced by discussions held with stakeholders in this domain. The report features detailed transcripts of interviews held with the industry stakeholders.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

RESEARCH METHODOLOGY

The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews / surveys with experts in this domain (academia, industry, medical practice, and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Wherever possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include:

While the focus has been on forecasting the market till 2035, the report also provides our independent views on various technological and non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research, and understanding of the relevant market gathered from various secondary and primary sources of information.

KEY QUESTIONS ANSWERED

Question 1: What is the growth rate of quantum computing market focusing on drug discovery?

Answer: The global quantum computing market focusing on drug discovery is expected to grow at an annualized rate of 14% from 2023 to 2035.

Question 2: Which region is likely to hold the largest share in the quantum computing market focused on drug discovery?

Answer: North America is anticipated to capture the highest market share by 2035. In addition, the market in Asia-Pacific is likely to grow at a relatively faster pace, in the long term.

Question 3: Which type of service providers are most likely to dominate the quantum computing market for drug discovery?

Answer: Currently, software providers hold the largest share in the quantum computing in drug discovery services market; this is followed by hardware providers.

Question 4: What kind of partnership models are most commonly being adopted by stakeholders engaged in this domain?

Answer: Research and development agreements emerged as the most popular type of partnership model adopted by players engaged in offering quantum computing services for drug discovery. This is followed by platform utilization agreements.

CHAPTER OUTLINES

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE: SOFTWARE PROVIDERS

5. COMPANY COMPETITIVENESS ANALYSIS

6. COMPANY PROFILES: SOFTWARE PROVIDERS

7. MARKET LANDSCAPE: HARDWARE PROVIDERS

8. COMPANY PROFILES: HARDWARE PROVIDERS

9. ACADEMIC GRANTS ANALYSIS

10. PARTNERSHIPS AND COLLABORATIONS

11. USE CASE STUDY

12. PORTER'S FIVE FORCES ANALYSIS

13. BLUE OCEAN STRATEGY: A STRATEGIC GUIDE FOR START-UPS TO ENTER INTO HIGHLY COMPETITIVE MARKET

14. MARKET SIZING AND OPPORTUNITY ANALYSIS

15. EXECUTIVE INSIGHTS

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â